Biohippo Inc.
Gaithersburg, MD
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 900 Clopper Rd #140, Gaithersburg, MD 20878, USA
- Website
- ebiohippo.com
- Founded
- 2017
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $5,500 |
| FY2024 | $94,274 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Biohippo Inc. is a self-certified small disadvantaged business registered in SAM.gov since December 6, 2018, with an active registration until August 8, 2025. As a for-profit corporate entity, the company specializes in providing advanced biomedical research services and equipment, with a primary focus on creating sophisticated animal models and genetic research tools. The organization operates as a prime contractor, consistently working with various institutes within the National Institutes of Health (NIH) to support cutting-edge scientific research initiatives.
Through its federal contract awards, Biohippo Inc. has demonstrated extensive expertise in developing complex genetic research tools, specifically custom animal models and specialized mouse strains for various NIH research institutes. The company has consistently secured purchase order contracts from multiple NIH agencies, including the National Institute of Neurological Disorders and Stroke (NINDS), National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Aging (NIA), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and the National Institute on Deafness and Other Communication Disorders (NIDCD). Their services encompass constructing custom conditional knockout mice, generating specific gene-modified mouse lines, performing gene detection and quality control reporting, and providing specialized research animal models using advanced techniques like CRISPR/Cas9 technology. Most of their contracts are firm-fixed-price purchase orders ranging from $2,774 to $24,500, with no specific set-aside designations except for one Total Small Business contract. The contracts typically have completion dates within 6-12 months and support various research protocols across different medical and scientific domains.
Quick answers
Is Biohippo Inc. registered in SAM.gov?
Yes. Biohippo Inc.'s SAM.gov registration is active through August 3, 2027.
What is Biohippo Inc.'s CAGE code?
Biohippo Inc.'s CAGE code is 87SR1, and its Unique Entity ID (UEI) is S969JZ9MKUH3.
How much has Biohippo Inc. received in federal contracts?
Federal contracts obligated $5,500 to Biohippo Inc. in fiscal year 2025 and $99,774 in fiscal years 2023 through 2027.
What is Biohippo Inc.'s most recent federal award?
Biohippo Inc.'s most recent federal contract award is PLVAP1-CRE-ER mice to study vascular fenestrations in the CNS (75N95A25P00010), from National Institute of Neurological Disorders and Stroke (NIH), on December 17, 2024.
On GovTribe
See Biohippo Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors